Transcriptional alteration of DNA repair genes in Philadelphia chromosome negative myeloproliferative neoplasms-Reference-Cited by-同舟云学术

Transcriptional alteration of DNA repair genes in Philadelphia chromosome negative myeloproliferative neoplasms

Published:2019-11-20 Issue:12 Volume:98 Page:2703-2709
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Kirschner Martin^ORCID,Bornemann Anne,Schubert Claudia,Gezer Deniz,Kricheldorf Kim,Isfort Susanne,Brümmendorf Tim H.,Schemionek Mirle,Chatain Nicolas,Skorski Tomasz,Koschmieder Steffen

Funder

Deutsche Forschungsgemeinschaft

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-019-03836-2.pdf

Reference28 articles.

1. Barbui T, Barosi G, Birgegard G, Cervantes F, Finazzi G, Griesshammer M, Harrison C, Hasselbalch HC, Hehlmann R, Hoffman R, Kiladjian JJ, Kröger N, Mesa R, McMullin M, Pardanani A, Passamonti F, Vannucchi AM, Reiter A, Silver RT, Verstovsek S, Tefferi A, European LeukemiaNet (2011) Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet. J Clin Oncol 29(6):761–770

2. Tefferi A, Cortes J, Verstovsek S, Mesa RA, Thomas D, Lasho TL, Hogan WJ, Litzow MR, Allred JB, Jones D, Byrne C, Zeldis JB, Ketterling RP, McClure R, Giles F, Kantarjian HM (2006) Lenalidomide therapy in myelofibrosis with myeloid metaplasia. Blood 108(4):1158–1164

3. Tefferi A (2012) JAK inhibitors for myeloproliferative neoplasms: clarifying facts from myths. Blood 119(12):2721–2730

4. Tefferi A, Lasho TL, Finke CM, Knudson RA, Ketterling R, Hanson CH, Maffioli M, Caramazza D, Passamonti F, Pardanani A (2014) CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons. Leukemia 28(7):1472–1477

5. Iglehart JD, Silver DP (2009) Synthetic lethality--a new direction in cancer-drug development. N Engl J Med 361(2):189–191

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploiting Synthetic Lethality between Germline BRCA1 Haploinsufficiency and PARP Inhibition in JAK2V617F-Positive Myeloproliferative Neoplasms;International Journal of Molecular Sciences;2023-12-16

2. Transcriptomic Analysis Reveals JAK2/MPL-Independent Effects of Calreticulin Mutations in a C. elegans Model;Cells;2023-01-02

3. Clinical potential of ATM inhibitors;Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis;2020-05